Pediatrix Medical (MD) Cash & Current Investments (2009 - 2026)

Pediatrix Medical has disclosed Cash & Current Investments across 18 years of filings, most recently posting $329.0 million for Q1 2026.

• In Q1 2026, Cash & Current Investments rose 50.1% year-over-year to $329.0 million; the TTM figure through Mar 2026 stood at $329.0 million (up 50.1% YoY), while the FY2025 annual figure was $499.7 million, up 43.39% from the prior year.
• Cash & Current Investments fell to $329.0 million in Q1 2026, from $499.7 million in the prior quarter.
• Over the last five years, Cash & Current Investments for MD reached as high as $499.7 million in Q4 2025 and fell as low as $96.8 million in Q1 2022.
• The 5-year median for Cash & Current Investments is $133.2 million (2024), against an average of $211.4 million.
• Annual changes were most pronounced in 2022 — Cash & Current Investments tumbled 78.84% — and 2025, when it jumped 161.51%.
• A 5-year view of Cash & Current Investments shows it stood at $103.1 million in 2022, then surged by 72.46% to $177.7 million in 2023, then surged by 96.07% to $348.5 million in 2024, then surged by 43.39% to $499.7 million in 2025, then tumbled by 34.17% to $329.0 million in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $329.0 million, $499.7 million, and $463.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.